[Effectiveness and limitations of adrenergic beta receptor  blocking in the treatment of the stenocardia syndrome and of some disorders of cardiac rhythm: clinical trial with INPEA (N-isopropyl-p-mitrophenylethanolamine)].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D010627:Phenethylamines / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D010627:Phenethylamines; D013565:Sympatholytics
Efficacia e limiti del blocco recettoriale beta-adrenergico nel trattamento della sindrome stenocardica e di alcune turbe del ritmo cardiaco: sperimentayione clinica condotta con INPEA (N-isopropil-p-nitrofentiletanolamina)